3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerBiliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract cancer, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, neoplasmRecruitingPhase 32026-09-14NCT06282575
Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic SyndromeFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, minimal change disease, nephritis, nephrosis, urinary system disorderActive, not recruitingPhase 32026-08-12NCT05914155
Selective Removal of Endometriotic Lesions Using CUSA Clarity in Ovarian EndometriomasAdnexal Diseases, Cysts, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, endocrine system disorder, endometriosis, female reproductive system disorder, gonadal disorder, neoplasm, ovarian cyst, ovarian disorderRecruitingNot stated2025-10-10NCT07215130